Cart
sales@molnova.com
Luteolin-3-O-beta-D-glucuronide
CAS No. 53527-42-7
Luteolin-3-O-beta-D-glucuronide( —— )
Catalog No. M24518 CAS No. 53527-42-7
Luteolin-3-O-beta-D-glucuronide is active in the inhibition of nitrite production in macrophages.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 214 | In Stock |
|
| 5MG | 150 | In Stock |
|
| 10MG | 269 | In Stock |
|
| 25MG | 523 | In Stock |
|
| 50MG | 737 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLuteolin-3-O-beta-D-glucuronide
-
NoteResearch use only, not for human use.
-
Brief DescriptionLuteolin-3-O-beta-D-glucuronide is active in the inhibition of nitrite production in macrophages.
-
DescriptionLuteolin-3-O-beta-D-glucuronide is active in the inhibition of nitrite production in macrophages.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53527-42-7
-
Formula Weight462.36
-
Molecular FormulaC21H16O12
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESO=C1C2=C(O)C=C(O)C=C2OC(C3=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)=C(O)C=C3)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.del Ba?o MJ, et al. Flavonoid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. postulation of a biosynthetic pathway. J Agric Food Chem. 2004 Aug 11;52(16):4987-92.
molnova catalog
related products
-
Ligucyperonol
Ligucyperonol exhibits significant activities on protecting muscle cells from mild to moderate oxidative stress.
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
-
PB28 dihydrochloride
σ2 receptor agonist
